The Fast Track designation is supported by data from a phase 2 trial that evaluated eRapa in 30 adult patients with FAP.
Considering taking supplements to treat sinonasal polyposis? Below is a list of common natural remedies used to treat or reduce the symptoms of sinonasal polyposis. Follow the links to read common ...
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and UseBiodexa plans to ...
Hosted on MSN1mon
Milk, Meat and Peanuts May Suppress Gut Tumors, Study Suggests"Small intestinal tumors are much rarer than those in the colon, but the risk is higher in cases of familial adenomatous polyposis," said lead researcher Hiroshi Ohno, from RIKEN IMS, in a statement.
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a therapeutic alternative with the potential to delay or prevent surgical removal ...
A free fatty acid form of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) reduces both the size and number of polyps in patients with familial adenomatous polyposis (FAP ...
Biodexa (NASDAQ:BDRX) stock soared 76% in morning trading after the company announced it has received FDA Fast Track designation for its drug eRapa for the treatment of familial adenomatous polyposis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback